Endpoint Clinical · 4 days ago
Director, Business Development
Endpoint Clinical is an interactive response technology systems and solutions provider that supports the life sciences industry. The Director, Business Development will primarily focus on identifying, developing, and winning U.S. new business opportunities.
Clinical TrialsComputerCRMInformation TechnologyInnovation ManagementSoftware
Responsibilities
Responsible for selling clinical trials software (RTSM/IRT) to pharmaceutical and biotech companies
Achieving company sales goals
Establish and maintain client relationships while prospecting for new opportunities
Educate customers on the value of a new software platform
Maintain accurate records and log all activities in our sales force automation system
Communicate weekly activities and coordinate sales pipeline with sales leadership
Prepare and deliver presentations to clients about the endpoint platform
Generate quotes and proposals using available templates
Participate in various trade shows and conferences
Assist in the creation of new sales plans and strategies
Negotiating budgets
Demonstrate efficient and accurate completion of all responsibilities
Winning customer awards for new business
Qualification
Required
Bachelor's degree or equivalent and/or appropriate experience
3 years RTSM/IRT or pharmaceutical services related sales experience
Proven track record of success in Business to Business Software sales
Ability to understand and communicate technical concepts
Proven ability to work independently as well as in a sales team environment
Organized with methodical approach for prospecting
Strong attention to detail
Excellent organizational and time management skills
Attentive listening skills
Excellent oral and written communication skills
Benefits
Medical
Dental
Vision
Life
STD/LTD
401(K)
Paid time off (PTO) or Flexible time off (FTO)
Company bonus where applicable
Company
Endpoint Clinical
Endpoint Clinical designs, engineers, and tests interactive response technology platforms that enables data access through phones.
Funding
Current Stage
Late StageTotal Funding
$1.7M2024-03-11Acquired
2010-03-01Debt Financing· $1.7M
Recent News
2025-08-13
Morningstar, Inc.
2025-03-20
Company data provided by crunchbase